Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth
BACKGROUND: The outgrowth of new vessels – angiogenesis – in the tumour mass is considered to be a limiting factor of tumour growth. To inhibit the matrix lysis that is part of the tumour angiogenesis, we employed the chimeric protein mhATF-BPTI, composed of the receptor binding part of the urokinas...
Tallennettuna:
| Julkaisussa: | BMC Cancer |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2002
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC122087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12147175/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2407-2-17 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|